Skip to main content

Dexcom U.S. revenue (change on a year)

  • DXCM · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$83.33+2.38%Close 13 Nov 2026 · Market value $30.61B

U.S. revenue (change on a year) at Dexcom came to 14% for the quarter to 30 Sep 2026, down 7.0 points from a year earlier.

As Dexcom reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.

By quarter

19%Jun 2024−2%Sep 20244%Dec 202415%Mar 202515%Jun 202521%Sep 202511%Dec 202511%Mar 202611%Jun 202614%Sep 2026
Dexcom U.S. revenue (change on a year), every reported period
Period endingU.S. revenue (change on a year)Change on a yearFiled
30 Sep 202614%down 7.0 points29 Oct 2026
30 Jun 202611%down 4.0 points30 Jul 2026
31 Mar 202611%down 4.0 points30 Apr 2026
31 Dec 202511%up 7.0 points12 Jan 2026
30 Sep 202521%up 23.0 points30 Oct 2025
30 Jun 202515%down 4.0 points30 Jul 2025
31 Mar 202515%—1 May 2025
31 Dec 20244%—13 Jan 2025
30 Sep 2024−2%—24 Oct 2024
30 Jun 202419%—25 Jul 2024

Definition

Revenue from this part of the business, as the company names and reports it in its results. Shown as the change on the same period a year earlier, as the company prints it. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Dexcom: · financial statements

Every KPI and segment of DXCM, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.